Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of HP-3060 in patients with perennial allergic rhinitis
jRCT2080222924Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of emedastine in perennial rhinitis, sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
emedastine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on jRCT2080222924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222924.